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Abstract
Background
Although rotavirus is the leading cause of severe diarrhea among children in sub-Saharan
Africa, better knowledge of circulating enteric pathogenic bacteria and their antimicrobial re-
sistance is crucial for prevention and treatment strategies.
Methodology/Principal Findings
As a part of rotavirus gastroenteritis surveillance in Maradi, Niger, we performed stool cul-
ture on a sub-population of children under 5 with moderate-to-severe diarrhea between
April 2010 and March 2012. Campylobacter, Shigella and Salmonella were sought with con-
ventional culture and biochemical methods. Shigella and Salmonella were serotyped by
slide agglutination. Enteropathogenic Escherichia coli (EPEC) were screened by slide ag-
glutination with EPEC O-typing antisera and confirmed by detection of virulence genes. An-
timicrobial susceptibility was determined by disk diffusion. We enrolled 4020 children,
including 230 with bloody diarrhea. At least one pathogenic bacterium was found in 28.0%
of children with watery diarrhea and 42.2% with bloody diarrhea. Mixed infections were
found in 10.3% of children. EPEC, Salmonella and Campylobacter spp. were similarly fre-
quent in children with watery diarrhea (11.1%, 9.2% and 11.4% respectively) and Shigella
spp. were the most frequent among children with bloody diarrhea (22.1%). The most fre-
quent Shigella serogroup was S. flexneri (69/122, 56.5%). The most frequent Salmonella se-
rotypes were Typhimurimum (71/355, 20.0%), Enteritidis (56/355, 15.8%) and Corvallis (46/
355, 13.0%). The majority of putative EPEC isolates was confirmed to be EPEC (90/111,
81.1%). More than half of all Enterobacteriaceae were resistant to amoxicillin and co-trimox-
azole. Around 13% (46/360) Salmonella exhibited an extended-spectrum beta-lactamase
phenotype.
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Conclusions
This study provides updated information on enteric bacteria diversity and antibiotic resis-
tance in the Sahel region, where such data are scarce. Whether they are or not the causa-
tive agent of diarrhea, bacterial infections and their antibiotic resistance profiles should be
closely monitored in countries like Niger where childhood malnutrition pre-disposes to se-
vere and invasive infections.
Introduction
Although diarrhea mortality rate among children under 5 years of age in sub-Saharan Africa
has been decreasing annually by about 4% since 2000, mortality remains high [1]. Of the
estimated 3.6 million child deaths in 2010, 12% were attributed to diarrheal diseases. The
incidence of childhood diarrhea in Africa has also decreased from 4.2 to 3.3 episodes per
child-year from 1990 to 2010, but sub-Saharan Africa still accounts for one third of diarrheal
episodes yearly (500 million of 1.7 billion worldwide), with the highest incidence among chil-
dren 6–11 months of age [2].
While rotavirus is the leading cause of severe diarrhea among children under 5 [3–5], with
about 30% of diarrhea cases being rotavirus positive in sub-Saharan Africa [6], many other vi-
ruses, parasites and bacteria cause serious diarrheal morbidity and mortality but are not vac-
cine preventable [7–12]. Among bacterial etiologies, typical enteropathogenic Escherichia coli
(EPEC) are associated with a higher risk of mortality in infants 0–11 months of age with mod-
erate-to-severe diarrhea and Shigella is the first or second cause of moderate-to-severe diarrhea
among children 1 to 5 years old [7,13].
The Sahel (an ecoregion lying between the Sudanian savanna to the south and the Sahara
desert to the north) bears the burden of some of the highest rates of diarrhea, malnutrition and
malaria among children under 5 [1]. The vicious cycle involving diarrheal disease and malnu-
trition places this population at higher risk of morbidity and mortality [7,14,15]. Moreover,
some diarrhea-causing agents like non-typhoidal Salmonella (NTS) were found to be the domi-
nant contributor to invasive bacterial disease with high mortality in Africa [16–18]. Several
studies in the Sahelian region showed that multi-drug resistant organisms have been emerging
over the last decades, with the general spread of resistance to amoxicillin, co-trimoxazole and
chloramphenicol [19–25]. Resistance to fluoroquinolones and extended-spectrum cephalospo-
rins (ESCs) in Enterobacteriaceae have also been reported to a lower extent [26–29]. Data on
the prevalence and antimicrobial resistance of the main circulating enteropathogenic bacteria
remain limited in the Sahel and in Niger in particular, due to the lack of laboratory facilities.
Yet, better knowledge of circulating endemic and epidemic enteric pathogens and their antimi-
crobial resistance is crucial for prevention, including vaccines against Shigella and diarrhea-
genic E. coli [30,31] and treatment strategies with antibiotics.
Here, we describe the main enteric and possibly pathogenic bacteria isolated from the stools
of children under 5 with moderate-to-severe diarrhea included in rotavirus gastroenteritis sur-
veillance in Maradi, Niger between April 2010 and March 2012.
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Materials and Methods
Study sites
Surveillance was set up as described previously [32] in the region of Maradi, located approxi-
mately 500 km away from the capital city Niamey. One regional hospital and 10 health centers
were included in four different health districts: Maradi (1 regional hospital), Madarounfa (3
health centers), Aguié (3 health centers) and Guidan Roumdji (4 health centers). After an ini-
tial period of one year of surveillance, surveillance was interrupted in the health district of
Aguié. The analysis presented here was restricted to a 24-month period from April 2010 to
March 2012.
Study population
Children were included in the general rotavirus surveillance study if they were aged 0 to 59
months, consulting at a study site with watery diarrhea and signs of moderate or severe dehy-
dration, and if the parent or legal guardian accepted participation in the study. Children with
reported bloody diarrhea were included during the second year [32]. A sub-sample of the chil-
dren included in the general rotavirus surveillance was selected to participate in the sub-study
on bacterial etiology of diarrhea. These children were: the first child included daily with watery
diarrhea at each health center; the first 2 children included daily with watery diarrhea at the re-
gional hospital; all included children with reported bloody diarrhea and producing stool
specimens.
Data and specimen collection
A standardized questionnaire was used to collect socio-demographic characteristics (sex, age),
clinical presentation (dehydration, fever, vomiting), medical care (rehydration treatment, hos-
pitalization, inclusion in a nutritional program) and outcomes.
At the health centers, stool specimens were collected using sterile plastic containers and sys-
tematically tested for rotavirus using Vikia Rota-Adeno rapid test (bioMérieux, Marcy l’Etoile,
France) [32]. Stool samples were then transferred onto Cary-Blair medium (Oxoid, Basing-
stoke, UK) using sterile swab and stored at +2–8°C until transported in cold containers to the
Epicentre laboratory in Maradi city every other day. At the Maradi regional hospital, we main-
tained the fresh stools at +2–8°C before transfer to the laboratory within 1 hour after sampling.
Stool culture, bacterial identification and antimicrobial susceptibility
testing
The bacterial pathogens sought included Salmonella spp, Shigella spp, EPEC, and, starting
from July 2010, Campylobacter spp. Upon arrival at the laboratory, swabs from the Cary-Blair
tubes or fresh stools were plated onto desoxycholate citrate lactose media (DCL, Bio-Rad,
Marnes-la-Coquette, France), Hektoen media (HK, Bio-Rad), Butzler media (Oxoid) and Mull-
er-Kauffmann broth (MK, AES Chemunex, Combourg, France). DCL, HK and MK were incu-
bated at 37°C in normal atmosphere. Butzler media were incubated for 48h in microaerophilic
atmosphere using atmospheric generator (bioMérieux). After 18h incubation, 10μL of MK
broth were inoculated onto Chromagar Salmonellamedia (ChromAgar, Paris, France) and in-
cubated for an additional 18–24 h. After incubation, suspected colonies of Salmonella and Shi-
gella spp. were submitted to metabolic identification using API strips (bioMérieux) and
partially serogrouped by slide agglutination using polyvalent SalmonellaO-typing antisera
(Bio-Rad). From DCL media, between 1 and 10 lactose-fermenting colonies were picked and
tested by slide agglutination with EPEC O-typing antisera (Bio-Rad). Twelve EPEC serogroups
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were targeted by the four polyvalent antisera used: I (O111, O55, O26), II (O86, O119, O127),
III (O125, O126, O128), and IV (O114, O124, O142). These serogroups corresponded to those
recognized as being EPEC by the World Health Organization (WHO) in 1987, with the excep-
tion of O124 which was replaced by O158 in the WHO definition [33]. Reactive colonies were
subsequently isolated and confirmed as E. coli using API strips. Campylobacter isolates were
identified by colony aspect on Butzler media, Gram stain examination, oxidase (+) and catalase
(+). The sodium hippurate hydrolysis test was then performed to differentiate C. jejuni from C.
coli.
Antimicrobial susceptibility of each isolate was determined by the disk diffusion method on
Mueller- Hinton agar (+5% sheep blood for Campylobacter spp) as recommended by the Anti-
biogram Committee of the French Society for Microbiology (CA-SFM) [34]. The panel of the
13 antimicrobials tested (Bio-Rad) was amoxicillin (AMX, 25μg), amoxicillin-clavulanic acid
(AMC, 20/10μg), cefalotin (CF, 30μg), cefotaxime (CTX, 30μg), ceftazidime (CAZ, 30μg), cefe-
pime (FEP, 30μg), imipenem (IPM, 10μg), nalidixic acid (NA, 30μg), ciprofloxacin (CIP, 5μg),
co-trimoxazole (trimethoprim-sulfamethoxazole, SXT, 1,25/23,75μg), gentamicin (GM, 15μg),
amikacin (AN, 30μg), and erythromycin (for Campylobacter spp. only, E, 15UI). Extended-
spectrum β-lactamase (ESBL) phenotype was assessed by using the double-disk synergy (DDS)
method [34] on isolates displaying resistance or intermediate resistance to ESCs. The isolates
displaying resistance to ciprofloxacin by disk diffusion were confirmed by determination of the
minimal inhibitory concentration (MIC) using Etest strips (bioMérieux). CA-SFM breakpoints
were used for disk diffusion and the European Committee on Antimicrobial Susceptibility
Testing (EUCAST) breakpoints were used for MIC. E. coli strain CIP 76.24 (ATCC 25922) was
used as a quality control strain.
Typing of Shigella and Salmonella
Salmonella (n = 370) and Shigella (n = 138) isolates were stored at Epicentre laboratory then
sent to the French National Reference Center for E. coli, Shigella and Salmonella (FNRC-ESS),
Institut Pasteur, Paris. Species identification was confirmed using conventional methods and
serotyping was done by slide agglutination assays using a complete set of antisera allowing rec-
ognition of all described Salmonella [35] and Shigella [36] serotypes. Typing antisera were pur-
chased from Bio-Rad, Eurobio (Les Ulis, France), Statens Serum Institute (Copenhagen,
Denmark), Sifin (Berlin, Germany) or were homemade at the FNRC-ESS. Two serotype Ken-
tucky isolates were typed by multilocus sequence typing (MLST) as described previously [37].
Characterization of EPEC isolates
All putative EPEC isolated from rotavirus-positive children (n = 37) and a random sample of
putative EPEC isolated from rotavirus-negative children in 2010 (n = 74) were sent to the
FNRC-ESS for confirmation and serotyping. All isolates were subjected to the following bio-
chemical tests: motility, glucose (acid and gas), H2S, indole production, lysine decarboxylase,
ornithine decarboxylase, glycerol, lactose, d-mannitol, and sorbitol. DNA was extracted from
all phenotypically confirmed E. coli isolates with the InstaGene matrix kit (Bio-Rad). PCR was
used to detect the uidA gene encoding the beta-glucuronidase; thus confirming the assignment
of the isolates to E. coli and to detect several virulence genes associated with EPEC and other
diarrheagenic E. coli. The targeted virulence genes were (i) eae (for EPEC attaching and effac-
ing), which encodes intimin, an outer membrane adhesin essential for the intimate attachment
of the EPEC or enterohemorrhagic E. coli (EHEC) to enterocytes, (ii) bfpA (for bundle-forming
pilus) carried by the EPEC adherence factor (EAF) plasmid found in typical EPEC, (iii) stx1
and stx2 encoding Shiga toxins, markers of EHEC, (iv) EHEC-hlyA encoding the hemolysin of
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EHEC, (v) in case of eae negativity, aggR, a transcriptional activator of aggregative adherence
fimbriae expression in enteroaggregative Escherichia coli (EAEC), (vi) and in case of eae and
aggR negativity, lt and st genes of enterotoxigenic E. coli (ETEC) and ial and ipah genes of
enteroinvasive E. coli (EIEC). The different primers and basic amplification conditions are de-
scribed in S1 Table [38–47]. All E. coli isolates that contained at least one virulence gene were
serogrouped by slide agglutination using at first polyvalent I (O26, O44, O114, O125, O142,
O158), II (O55, O86, O91, O111, O119, O126, O127, O128), III (O25, O78, O103, O118, O124,
O145, O157, O164) and A (O1, O2, O18, O78) antisera from Sifin; then if needed (i.e., in case
of an agglutination with a polyvalent antiserum) the corresponding monovalent antisera, also
from Sifin. Not serotypable E. coli isolates (rough phenotype due to the complete or partial loss
of lipopolysaccharide and leading to autoagglutination or no agglutination with the panel of
antisera) were O-typed by a molecular method based on the analysis of the O-antigen gene
cluster (rfb restriction fragment length polymorphism [rfb-RFLP]) after DNA extraction with
the InstaGene matrix kit (Bio-Rad) [48].
Data analysis
Double data entry was done using EpiData 3.1 (EpiData, Odense, Denmark), and data analysis
using Stata 12.1 (College Station, Texas, USA). Severe diarrhea was defined using the 20-point
Vesikari scale with a score11 [49]. We performed a weighted analysis by month and district
of inclusion to take into account the selection process when estimating the proportion and sea-
sonality of the bacterial pathogens. For Salmonella and Shigella spp., only the isolates that were
confirmed at FNRC-ESS are considered in this analysis.
Ethical Considerations
The study protocol was approved by the National Ethical Committee of Niger’s Ministry of
Public Health (Ref n° 02/2009/CCNE) and by the Comité de Protection des Personnes, Ile-de-
France XI, France. Participation was voluntary. An informed consent statement was read aloud
in the local dialect before consenting parent or legal guardian signed or fingerprinted (proce-
dures approved by both ethical committees). All children received treatment free of charge.
Results
Characteristics of the study population
In total, 8993 children were included in the rotavirus surveillance study from April 2010 to
March 2012. Of these, we excluded 117 because of a delay between admission and testing of
more than 3 days, 4 without clinical signs of dehydration, and 37 who sought care 14 days
after onset of diarrhea. The 8835 remaining comprised 8566 children with watery diarrhea, of
which 3790 (44.3%) were selected for the bacteriological study; and 269 with bloody diarrhea,
of which 230 (85.5%) were also included in the bacteriological study.
Due to the selection process of children for the bacteriological study (i.e. inclusion of the
first child per day in all health centers and first 2 children per day at Maradi hospital), children
included in Maradi district (i.e. at the Maradi regional hospital), hospitalized children and in-
travenous treatment are over-represented compared to the initially enrolled population
(Table 1). Other characteristics, such as sex, age, presence of fever, inclusion in a nutritional
program and mortality were similar to the initial population (Table 1). Children with bloody
diarrhea showed significantly less vomiting and a lower proportion of severe diarrhea accord-
ing to the Vesikari score, compared to those with watery diarrhea (Table 1).
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Proportion of pathogenic bacteria, seasonal distribution and clinical
characteristics
Overall, at least one pathogenic bacterium was found in 1060 (28.0%) children with watery di-
arrhea and 97 (42.2%) children with bloody diarrhea. EPEC, Salmonella spp. and Campylobac-
ter spp. were similarly frequent in children with watery and bloody diarrhea and Shigella spp.
were the most frequent among children with bloody diarrhea (Table 2). Mixed infections (i.e.
association with rotavirus or any other bacteria) were found in 10.3% of children overall. Fifty-
four children (1.3%) with sterile stool culture after 48h were excluded from all the
subsequent analyses.
When the weighted proportions were extrapolated to the number of diarrhea cases, the sea-
sonal distribution of pathogens showed a consistent peak of EPEC in March to June, when 54%
of EPEC diarrhea occurred annually. There was a peak of Salmonella spp. in October to Janu-
ary during the first year with 50% of all Salmonella diarrhea (mean 27 cases per month). This
same amplitude was not found the second year (mean 13 cases per month) (S1 Fig.).
While the proportion of EPEC and rotavirus decreased with age, the proportion of Salmo-
nella spp. increased (Fig. 1). All demographic and clinical characteristics showed significant
differences among infection categories with the exception of sex (Table 3). The main associa-
tions after exclusion of mixed-infections were the following: Campylobacter infections with
moderate dehydration (p = 0.007); EPEC infections with vomiting (p = 0.011) and severe dehy-
dration (p<0.001); Salmonella infections with severe dehydration (p<0.001), fever (p = 0.016)
and inclusion in a nutrition program (p<0.001); Shigella infections with deaths (p = 0.003); fi-
nally rotavirus infections with vomiting (p<0.001) and with non-inclusion in a nutrition
Table 1. Socio-demographic and clinical characteristics of children with watery or bloody diarrhea, included in the bacteriology sub-study.
Watery diarrhea
(N = 3790)
p* Bloody diarrhea
(N = 230)
p‡
n % n %
District of inclusion <0.001 <0.001
Maradi 658 17.4 37 16.1
Madarounfa 1201 31.7 54 23.5
Guidan Roumdji 1482 39.1 139 60.4
Aguié 449 11.8 0 0.0
Socio-demographic
Male 2103 55.5 0.34 125 54.4 0.75
Age, median [IQR] 9 [7–12] 12 [9–19]
Clinical characteristics
Severe dehydration 581 15.3 0.11 44 19.1 0.12
Fever 852 22.5 0.53 62 27.0 0.12
Vomiting 2461 65.0 0.006 105 46.1 <0.001
Vesikari score  11 2759 72.9 0.54 128 55.7 <0.001
Hospitalisation and outcome
IV treatment 447 11.8 <0.001 21 9.1 0.22
Hospitalisation 804 21.2 <0.001 39 17.0 0.13
Included in a nutritional program 722 19.0 0.56 52 22.6 0.18
Deaths 56 1.5 0.41 7 3.0 0.06
* Comparison with children with watery diarrhea included in the surveillance study but not included in the bacteriology study
‡ Comparison between children with watery or bloody diarrhea
doi:10.1371/journal.pone.0120275.t001
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program (p<0.001), as described elsewhere [32]. While all isolated Campylobacter were C.
jejuni, diversity of the other pathogens is described below.
Shigella and Salmonella diversity
Of 143 isolates initially identified as Shigella, 138 were sent to the FNRC-ESS. The missing iso-
lates were due to storage difficulties after strain identification. Ten (10) strains were not con-
firmed as Shigella spp., leaving 128 confirmed Shigella isolates. Of these, 6 were not serotypable
(four were rough and two were non-agglutinable with the panel of typing antisera). Of the 122
serotyped isolates, the most frequent serogroups were S. flexneri (n = 69, 56.5%), followed by S.
dysenteriae (n = 24, 19.7%), S. boydii (n = 21, 17.2%), and finally S. sonnei (n = 8, 6.6%). Two
isolates belonged to S. dysenteriae type 1, the causative agent of epidemic dysentery. Details of
serotypes identified are provided in Table 4.
Of the 383 isolates initially identified as Salmonella, 370 were sent to the FNRC-ESS. The
missing isolates were due to storage difficulties after strain identification. Nine (9) strains were
not confirmed as Salmonella spp., one could not be subcultured, leading to 360 confirmed Sal-
monella isolates. In addition, 7 were not serotypable (rough). Two cultures contained more
than one serotype; a mixture of serotypes Serenli and Suelldorf in one and a mixture of sero-
types Mbao and Herston in the other. Among the 355 Salmonella serotypes, the most frequent-
ly encountered were Typhimurimum (n = 71, 20.0%), Enteritidis (n = 56, 15.8%), and Corvallis
(n = 46, 13.0%) (Table 5). Another 64 serotypes were identified with less than 20 isolates for
each, including S. enterica serotype Typhi (two isolates), the agent of typhoid fever and two po-
tential new serotypes belonging to subspecies enterica. These potential new serotypes with anti-
genic formulae 44:z:z6 (one isolate) and 47:d:1,5 (two isolates) were sent to the World Health
Organization Collaborative Center for Reference and Research on Salmonella, Institut Pasteur,
Paris for confirmation and incorporation into the White-Kauffmann-Le Minor scheme. One
with antigenic formula 47:d:1,5 has be confirmed and named serotype Maradi, while the other
is still under study.
Table 2. Weighted proportion of enteric bacterial pathogens and rotavirus among children with watery and bloody diarrhea.
Watery diarrhea Bloody diarrhea
n % 95% CI n % 95% CI
All
Putative EPEC* 416 11.1 [10.1–12.2] 20 9.4 [6.1–13.2]
Salmonella spp. 340 9.2 [8.2–10.3] 20 8.7 [5.8–13.4]
Shigella spp. 78 2.0 [1.6–2.5] 50 22.1 [17.1–28.1]
Campylobacter spp. ‡ 350 11.4 [10.2–12.6] 20 8.8 [5.7–13.3]
Rotavirus 1192 33.8 [32.2–35.5] 15 6.2 [3.7–10.1]
Mixed infections excluded
Putative EPEC* 289 7.5 [6.6–8.4] 10 4.3 [2.3–7.9]
Salmonella spp. 184 4.8 [4.1–5.5] 15 6.7 [4.0–10.9]
Shigella spp. 54 1.3 [1.0–1.7] 42 18.2 [13.6–23.8]
Campylobacter spp. ‡ 178 4.9 [4.2–5.7] 11 4.8 [2.7–8.5]
Rotavirus 917 26.2 [24.7–27.8] 10 4.2 [2.2–7.7]
* Including all isolates identiﬁed as putative EPEC in Maradi
‡ Analysis restricted to July 2010-March 2012
doi:10.1371/journal.pone.0120275.t002
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Fig 1. Distribution of organism identified in children with watery or bloody diarrhea by age group.
doi:10.1371/journal.pone.0120275.g001
Table 3. Demographic and clinical characteristics of children with watery or bloody diarrhea by agent identified from stools, after exclusion of
mixed infections.
No pathogen Campylobacter
spp.
EPEC spp. Salmonella
spp.
Shigella spp. Rotavirus p
N = 1882 N = 189 N = 299 N = 199 N = 96 N = 928
Sex, males, % (95% CI) 54.8 (52.5–
57.0)
57.1 (50.0–64.2) 56.2 (50.6–
61.8)
57.3 (50.4–
64.2)
56.3 (46.3–
66.2)
55.3 (52.1–
58.5)
0.98
Age in months, mean (SD) 11.8 (7.0) 12.0 (6.0) 8.8 (4.1) 15.2 (7.7) 13.7 (6.7) 8.6 (4.2) <0.001
N° of stools in the last 24h,
mean (SD)
6.1 (1.6) 6.3 (1.5) 6.1 (1.7) 6.3 (1.6) 6.6 (1.5) 6.5 (1.6) <0.001
Vomiting, % (95% CI) 55.0 (52.7–
57.2)
54.8 (47.7–61.9) 69.9 (64.7–
75.1)
52.7 (45.8–
59.7)
48.9 (38.8–
59.1)
82.1 (79.7–
84.6)
<0.001
Severe dehydration, % (95% CI) 14.9 (13.3–
16.6)
8.5 (4.5–12.5) 24.4 (19.5–
29.3)
24.1 (18.2–
30.1)
19.8 (11.8–
27.8)
12.5 (10.4–
14.6)
<0.001
Fever, % (95% CI) 22.8 (20.9–
24.7)
23.3 (17.2–29.3) 23.4 (18.6–
28.2)
29.1 (22.8–
35.5)
29.1 (22.8–
35.5)
20.2 (17.6–
22.8)
0.07
Vesikari score, mean (SD) 11.8 (2.5) 11.7 (2.6) 12.6 (2.5) 12.1 (2.6) 11.4 (2.5) 12.7 (2.0) <0.001
Death, % (95% CI) 1.5 (0.9–2.0) 1.1 (0.0–2.5) 2.3 (0.6–4.1) 2.0 (0.1–4.0) 5.2 (0.7–9.7) 0.9 (0.3–1.5) 0.031
In nutritional program 21.5 (19.6–
23.3)
17.5 (12.0–22.9) 20.1 (15.5–
24.6)
29.6 (23.3–
36.0)
27.1 (18.1–
36.0)
12.2 (10.1–
14.3)
<0.001
doi:10.1371/journal.pone.0120275.t003
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Characterization of EPEC isolates
Of the 436 isolates initially screened as putative EPEC isolates by O serogrouping, a random
sample of 74 isolates selected from rotavirus-negative children and all 37 isolates from rotavi-
rus-positive children isolated in 2010 were characterized at the FNRC-ESS. Of these 111 iso-
lates, 104 (93.7%) were confirmed as E. coli based on biochemical and phenotypic reactions,
and 90/104 (86.5%) were confirmed to be EPEC due to the presence of the eae gene encoding
intimin and the absence of other EHEC-associated virulence genes, stx1, stx2, and EHEC-hlyA
(S2 Table). Of the 90 EPEC, 88 (97.8%) were typical EPEC due to the presence of the bfpA gene
carried by the EAF plasmid. Of the 14 other E. coli, 6 were actually EAEC due to the presence
of the aggR gene and 8 did not contain any of the targeted virulence genes and were probably
not pathogenic E. coli. The most frequent EPEC serogroups were O55 (32/90, 35.5%), O126
and O119 (13/90, 14.4% each) (S2 Table). All but two EAEC also belonged to O55. Four of the
8 isolates without virulence genes belonged to serogroups common to EPEC such as O26,
O114 and O126. There was no significant difference in the proportion of intimin-positive iso-
lates among E. coli isolated in rotavirus-positive or negative children (p = 0.37).
Table 4. Shigella serotypes identified in the study.
Shigella serotypes n %
S. ﬂexneri 69 56.5
S. ﬂexneri 1b 17
S. ﬂexneri 2a 17
S. ﬂexneri 6 Boyd 88 8
S. ﬂexneri 2b 7
S. ﬂexneri 3a 7
S. ﬂexneri 4 5
S. ﬂexneri Y 5
S. ﬂexneri 1c 2
S. ﬂexneri 3b 1
S. dysenteriae 24 19.7
S. dysenteriae 2 16
S. dysenteriae 3 4
S. dysenteriae 1 2
S. dysenteriae 12 2
S. boydii 21 17.2
S. boydii 12 9
S. boydii 1 3
S. boydii 2 3
S. boydii 5 2
S. boydii 3 1
S. boydii 4 1
S. boydii 10 1
S. boydii 18 1
S. sonnei 8 6.6
S. sonnei g 8
Total* 122 100
*Not including the four rough (auto-agglutinable) and the two non-agglutinable isolates
doi:10.1371/journal.pone.0120275.t004
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Antimicrobial resistance
Around 2% (6/328) of Campylobacter jejuni were resistant to amoxicillin-clavulanic acid and
erythromycin, with 5 isolates resistant to both. More than half of all Enterobacteriaceae, and
up to 90% of EPEC isolates were resistant to amoxicillin and co-trimoxazole, while they were
mostly sensitive to all other antibiotics tested (Table 6). Among Shigella isolates, S. flexneri
(71.8%) were more resistant to amoxicillin than S. sonnei (12.5%), but similarly resistant to co-
trimoxazole (86.0% in S. flexneri and 100% in S. sonnei). The two S. dysenteriae type 1 isolates
were resistant to amoxicillin and susceptible to other tested drugs. Forty-six Salmonella and
Table 5. Salmonella serotypes identified in the study (N = 355).
Subspecies Serotypes n Subspecies Serotypes n
I. Aberdeen 2 I. Mbao 5
I. Adelaide 5 I. Menston 1
I. Agona 1 I. Mesbit 1
I. Ank 2 I. Molade 1
I. Antsalova 1 I. Montevideo 4
I. Banana 11 I. Muenchen 2
I. Belem 1 I. Muenster 4
I. Brandenburg 1 I. Ona 1
I. Carmel 2 I. Oranienburg 4
I. Cerro 4 I. Poona 6
I. Chester 3 I. Rissen 1
I. Colindale 7 I. Rubislaw 3
I. Corvallis 46 I. Saintpaul 1
I. Denver 2 I. Serenli 2
I. Derby 1 I. Stanleyville 1
I. Ealing 1 I. Suelldorf 1
I. Eastbourne 1 I. Telelkebir 1
I. Elisabethville 1 I. Tennessee 4
I. Enteritidis 56 I. Tilene 3
I. Evry 1 I. Typhi 2
I. Freetown 2 I. Typhimurium 71
I. Gaminara 3 I. Urbana 2
I. Give 8 I. Vejle 7
I. Gombe 1 I. Virchow 1
I. Hadar 1 I. Waycross 1
I. Hato 2 I. Wimborne 4
I. Havana 6 I. Zinder 3
I. Herston 1 I. Provisional new serotype I 44:z:z6 1
I. Hull 1 I. New serotype Maradi (47:d:1,5) 2
I. Johannesburg 15 I. 1,3,19:d:- (monophasic) 3
I. Kalina 2 I. 4,5,12:-:1,2 (monophasic) 1
I. Kentucky 2 I. 4,5,12:i:- (monophasic) 4
I. Maastricht 12 IIIa. 41:z4,z23:-:- 1
I. Magherafelt 1
I., subspecies enterica; IIIa, subspecies arizonae; the 7 isolates (6 belonging to subsp. enterica and one to subsp. salamae) with a rough phenotype were
not included.
doi:10.1371/journal.pone.0120275.t005
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one EPEC isolate were resistant to ESCs and exhibited an ESBL phenotype. All the 46 ESBL-
producing Salmonella belonged to serotype Corvallis. The majority of these isolates were also
resistant to gentamicin (n = 31) and intermediate or resistant to ciprofloxacin (n = 23, MICs
range 1–3 mg/L). Although there was a peak of ESBL-producing S. enterica serotype Corvallis
in November 2010 (n = 13), the others were isolated throughout the study period. The district
of origin of children with ESBL-producing Salmonella infection was more likely to be Maradi
(41.3%, n = 19) compared to children with any Salmonella infection (12.0%, p<0.001). Howev-
er, ESBL-producing S. enterica serotype Corvallis were also isolated from Guidan-Roumdji
(n = 13), Madarounfa (n = 9) and other districts. Regarding resistance to ciprofloxacin, in addi-
tion to Corvallis isolates, only two other isolates were resistant (MICs 16 mg/L). Both isolates
belonged to serotype Kentucky and were ST198 by MLST.
Discussion
Almost one-third of children were infected with or carried a bacterial pathogen and around
one in ten presented co-infections with either another bacterial pathogens or rotavirus, consis-
tent with what has been found in other African countries [9,12]. Although it is widely recog-
nized that isolation of a bacterial pathogen from stool does not directly imply that the diarrhea
is attributable to this particular pathogen, the characterization of circulating agents in a popula-
tion still provides important information for the prevention and control of these infections and
can complement case-control studies on diarrhea etiology. In case-control studies, rotavirus
and Shigella spp. are consistently reported as highly associated with diarrhea patients (cases),
EPEC shows significant but intermediate association, while Salmonella spp. and Campylobacter
are often found in similar proportions in patients with or without diarrhea [7,50,51]. Here, it is
thus difficult to conclude on the fractions of diarrhea cases attributable to each pathogen, ex-
cept for Shigella spp., which is probably responsible for around 2% of non-bloody diarrhea and
over 20% of bloody diarrhea in this area.
In our study, Shigella spp. were associated with the highest mortality overall and particularly
affected children included in a nutritional program, with a case fatality ratio of 15%. Most Shi-
gella spp. isolates were resistant to amoxicillin, although S. sonnei was mostly sensitive, similar
to what was described in Senegal and Central African Republic [23,52]. Resistance to ESCs and
fluoroquinolones was not found here, which is also consistent with the low prevalence in other
reports from Africa and in contrast with the emergence of resistance in Asia [9,52–55]. The iso-
lated Shigella serotypes showed the typical pattern described in developing countries with a
clear predominance of S. flexneri, in particular over S. sonnei [56]. Several Asian countries have
recently experienced a transition from predominance of S. flexneri to S. sonnei, probably due to
improvement of overall nutritional status, sanitation and socioeconomic status [57–59]. The
few studies available from sub-Saharan Africa suggest that it is not yet the case in this area
[9,52,53,60], which emphasizes the need for vaccines including both species.
The isolation of S. dysenteriae type 1 from two children living in two different areas and 2
months apart indicates that this pathogen was still circulating in this area in 2011 but repre-
sented only 1.6% of all Shigella spp. and was not associated with outbreaks. The low level circu-
lation of S. dysenteriae type 1 was also observed in a survey conducted in an urban slum in
Nairobi, Kenya between 2007 and 2010 where S. dysenteriae type 1 represented 2.3% (6/262) of
Shigella spp. isolated [53]. Although no outbreak due to S. dysenteriae type 1 has been reported
in Africa since 2003–2004 [61], these studies document the low level circulation of Shiga’s ba-
cillus in two different regions of Africa where circumstances facilitating its transmission such
as overcrowding, poor or lack of sanitation or health facilities might trigger local outbreaks.
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Although screening for putative EPEC was based on O antigens (serogrouping) rather than
on the presence of virulence genes, the eae gene, marker of EPEC was found in the vast majori-
ty of isolates, confirming the good correlation between serogroups and virulence. However, the
identification method itself may be a limiting factor because it did not allow for the identifica-
tion of other E. coli enteric pathovars, and in particular ETEC, which was identified as the
cause of one third of the diarrhea attributable fraction (and first bacterial agent) in the GEMS
study [7]. EAEC were also found as the most frequent bacterial pathogens in children with di-
arrhea in Africa, particularly in infants [9,12,62]. In our study, EPEC was associated with youn-
ger age, as well as vomiting and severe dehydration. It was not associated with a higher risk of
dying, even in children less than 1 year (p = 0.11), in contrast to the 2.6 hazard ratio found in
GEMS [7]. EPEC isolates presented the highest resistance to amoxicillin and co-trimoxazole,
but were mostly sensitive to other antibiotics tested. The detection of one ESBL-producing
EPEC warrants attention in the context of increasing resistance in Africa [29,63].
We found that almost all EPEC (97.8%) were typical in agreement with other published
data [64]. Typical EPEC are associated with a human reservoir in low-income countries where-
as atypical EPEC are closer to Shiga toxin-producing E. coli and can be found either in humans
or animals of high-income countries. Interestingly, we identified typical EPEC belonging to a
new serogroup or to a serogroup (O26) previously associated only with atypical EPEC [64].
This could be due to a large diversity of EPEC populations circulating in low-income countries
and not well-known due to the lack of local studies requiring molecular biology for EPEC
confirmation.
Salmonella spp. were more frequently isolated in children included in a nutrition program,
the proxy used to define the population of malnourished children in our study. This suggests
that malnutrition could be a risk factor for Salmonella infection in general, and not only for in-
vasive non-typhoidal Salmonella infection [17]. The Salmonella peak around November 2010
corresponds to end of the annual malnutrition peak in Niger, and the number of children in-
cluded in a nutritional program during this period in our study was decreasing (data not
shown), suggesting that the 2 phenomena are temporally disconnected. This period also gener-
ally corresponds to the malaria peak in Niger, but we could not study possible associations be-
tween malaria and Salmonella isolation in diarrhea patients here since diagnosis of malaria was
not recorded. In addition, although there was a slight increase in the number of Salmonella de-
tected around November 2011, there was no clear peak and the seasonality of infection remains
to be confirmed.
Despite a wide variety of Salmonella serotypes identified, around half of the isolates be-
longed to serotypes Typhimurium, Enteritidis and Corvallis. While the 2 first are known to be
involved in a majority of diarrhea, as well as invasive NTS infections in Africa [17,65–67], sero-
type Corvallis has not been described as a major serotype so far. The fact that almost all sero-
type Corvallis isolates showed very similar antimicrobial resistance profiles, including ESBL
production, suggests that there was a clonal strain spreading in the area. This spread was dis-
seminated, in both space and time since it was found in all districts and during the whole study
period, with a peak in November 2010, along with other Salmonella spp. The comprehensive
characterization of these isolates as well as others from older and more recent surveys is ongo-
ing in order to elucidate the reservoir of this bacterial population. Two isolates of serotype Ken-
tucky highly resistant to ciprofloxacin were isolated. They belonged to the multi-drug resistant
S. enterica serotype Kentucky ST198-X1 strain which originated in Egypt during the 1990s, be-
fore disseminating across Africa, the Middle East, the Indian subcontinent and South East Asia
beginning in the mid-2000s [37,68].
Our study had several limitations. As mentioned above, the study was not designed to assess
attributable fractions and it is difficult to conclude on the precise etiology of diarrhea in this
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context. Since the required case-control studies for such a purpose are time- and resource-con-
suming, knowledge of pathogen and site-specific odds ratio from multicentric studies such as
GEMS would contribute to the interpretation of descriptive studies. In addition, the spectrum
of bacterial pathogens sought did not include some important bacteria such as ETEC, EAEC,
due to the lack of appropriate techniques (ie. PCR) to detect them on site. EHEC O157:H7,
which can be detected by culture using appropriate media, was also not investigated here since
it was not isolated in a previous study in the same area [18]. Media for the detection of V. cho-
lerae were available in case of suspicion of cholera, but were not used systematically.
In conclusion, this study provides updated information on enteric bacteria diversity and an-
timicrobial resistance in the Sahel region, where such data are scarce. Although rotavirus repre-
sents the first cause of diarrhea with dehydration, potentially pathogenic bacteria were found
in a similar proportion of children (~30%), sometimes in co-infection. Whether they are or not
the causative agent of diarrhea, bacterial infections and their antimicrobial resistance profiles
should be considered in areas with a large proportion of malnutrition, which pre-disposes to
severe and invasive infections. The emergence of ESBL-producing Salmonella spp. resistant to
all locally available antimicrobials should particularly be monitored. The wide serotype diversi-
ty, in particular for Shigella spp., should also be considered for vaccine development.
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